Literature DB >> 19874795

Factors contributing to anaemia after uncomplicated Plasmodiumfalciparum malaria in children.

Akintunde Sowunmi1, Grace O Gbotosho, Christian T Happi, Babasola A Fateye.   

Abstract

The factors contributing to anaemia in falciparum malaria were characterized in 1261 prospectively studied children in an endemic area of southwestern Nigeria. Of these, 487 (39%) presented with anaemia (haematocrit <30%). The following were found to be independent risk factors for anaemia at presentation: age <5 years, history of illness >3 days before presentation, presence of fever, a palpable liver, >parasitaemia 10,000/microl blood, and gametocytaemia. The mean maximum fractional fall in haematocrit (FFH) after treatment was 13.8% (95% confidence interval [CI] 13-14.6) of the baseline value. This occurred 3 days after treatment began and correlated positively with enrolment haematocrit. In children whose haematocrit was >30% at enrolment, the following were found to be independent risk factors associated with subsequent development of anaemia during follow-up: age <5 years and parasitaemia > or =100,000 parasites/microl. Haematological recovery was usually complete by 4-5 weeks, but was slower in children who were anaemic at enrolment and in those with recrudescence of their infections. Half of the children with recrudescence were still anaemic at 4 weeks. These findings have implications for the control of the burden of malarial anaemia in children in sub-Saharan African countries. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874795     DOI: 10.1016/j.actatropica.2009.10.011

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  12 in total

Review 1.  The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology.

Authors:  Pierre A Buffet; Innocent Safeukui; Guillaume Deplaine; Valentine Brousse; Virginie Prendki; Marc Thellier; Gareth D Turner; Odile Mercereau-Puijalon
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

2.  Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria.

Authors:  Grace O Gbotosho; Akintunde Sowunmi; Titilope M Okuboyejo; Christian T Happi; Onikepe A Folarin; Obaro S Michael; Elsie O Adewoye
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

3.  Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine.

Authors:  Ruth D Ellis; Michael P Fay; Issaka Sagara; Alassane Dicko; Kazutoyo Miura; Merepen A Guindo; Aldiouma Guindo; Mahamadou S Sissoko; Ogobara K Doumbo; Dapa Diallo
Journal:  Malar J       Date:  2011-01-19       Impact factor: 2.979

4.  Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children.

Authors:  Akintunde Sowunmi; Titilope M Okuboyejo; Grace O Gbotosho; Christian T Happi
Journal:  BMC Infect Dis       Date:  2011-10-09       Impact factor: 3.090

5.  Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification.

Authors:  Samuel O Oyola; Cristina V Ariani; William L Hamilton; Mihir Kekre; Lucas N Amenga-Etego; Anita Ghansah; Gavin G Rutledge; Seth Redmond; Magnus Manske; Dushyanth Jyothi; Chris G Jacob; Thomas D Otto; Kirk Rockett; Chris I Newbold; Matthew Berriman; Dominic P Kwiatkowski
Journal:  Malar J       Date:  2016-12-20       Impact factor: 2.979

6.  Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments.

Authors:  Akintunde Sowunmi; Kazeem Akano; Godwin Ntadom; Adejumoke I Ayede; Folasade O Ibironke; Temitope Aderoyeje; Elsie O Adewoye; Bayo Fatunmbi; Stephen Oguche; Henrietta U Okafor; Ismaila Watila; Martin Meremikwu; Philip Agomo; William Ogala; Chimere Agomo; Onikepe A Folarin; Grace O Gbotosho; Christian T Happi
Journal:  Infect Dis Poverty       Date:  2017-02-07       Impact factor: 4.520

7.  Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.

Authors:  Akintunde Sowunmi; Bayo Fatunmbi; Kazeem Akano; Olubunmi A Wewe; Chimere Agomo; Finomo Finomo; Joy Ebenebe; Nma Jiya; Jose Ambe; Robinson Wammanda; Godwin Ntadom; Olugbenga Mokuolu; George Emechebe; Nnenna Ezeigwe; Adejumoke I Ayede; Elsie O Adewoye; Grace O Gbotosho; Onikepe A Folarin; Christian T Happi; Stephen Oguche; Wellington A Oyibo; Francis Useh
Journal:  BMC Infect Dis       Date:  2017-12-19       Impact factor: 3.090

8.  Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.

Authors:  Akintunde Sowunmi; Kazeem Akano; Adejumoke I Ayede; Godwin Ntadom; Temitope Aderoyeje; Elsie O Adewoye; Bayo Fatunmbi
Journal:  BMC Infect Dis       Date:  2016-06-01       Impact factor: 3.090

9.  Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.

Authors:  Akintunde Sowunmi; Kazeem Akano; Adejumoke I Ayede; Godwin Ntadom; Bayo Fatunmbi; Temitope Aderoyeje; Elsie O Adewoye
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

10.  Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.

Authors:  Akintunde Sowunmi; Kazeem Akano; Adejumoke I Ayede; Elsie O Adewoye; Godwin Ntadom; Bayo Fatunmbi; Grace O Gbotosho; Onikepe A Folarin; Christian T Happi
Journal:  BMC Infect Dis       Date:  2017-01-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.